<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03702322</url>
  </required_header>
  <id_info>
    <org_study_id>R21DC016356</org_study_id>
    <nct_id>NCT03702322</nct_id>
  </id_info>
  <brief_title>Improving Voice Production for Adults With Age-related Dysphonia</brief_title>
  <official_title>Improving Voice Production for Adults With Age-related Dysphonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arizona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Arizona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives for this research are to determine the mechanisms by which specific therapy
      tasks improve voice in age-related dysphonia, and the conditions that limit the extent of
      improvement. The central hypothesis is that targeted therapy tasks will improve voice, and
      that severity will determine the extent of improvement.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">July 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All participants receive every intervention in randomized order</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Participants in the perceptual studies rating audio and visual files will be masked.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Relative glottal gap from laryngeal high-speed videoendoscopy</measure>
    <time_frame>End of year 3</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Perceived voice quality</measure>
    <time_frame>End of year 3</time_frame>
    <description>Participants will score the construct of &quot;overall voice quality&quot; using a technique called &quot;sort and rate&quot; in which listeners move icons representing each sound along a line. They align the icons so that best voices are on one side and worst voices are on the other. The distance between the icons represents how much better or worse one sound is than the other. There are no units to the scale. Rankings from all listeners are combined using the statistical technique of multidimensional scaling. The result is a ranked value for each sound file (i.e., voice production) that shows how different they are. There is no highest or lowest value.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acoustic measure of voice quality (Cepstral Peak Prominence)</measure>
    <time_frame>End of year 3</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Open quotient from laryngeal high-speed videoendoscopy</measure>
    <time_frame>End of year 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Speed index from laryngeal high-speed videoendoscopy</measure>
    <time_frame>End of year 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum area declination ratefrom laryngeal high-speed videoendoscopy</measure>
    <time_frame>End of year 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fundamental frequency standard deviation from laryngeal high-speed videoendoscopy</measure>
    <time_frame>End of year 3</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Presbylarynx</condition>
  <condition>Age-Related Dysphonia</condition>
  <arm_group>
    <arm_group_label>Participants</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All participants will undergo each treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Voice therapy: respiratory</intervention_name>
    <description>Abdominal voice onset</description>
    <arm_group_label>Participants</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Voice therapy: glottal closure</intervention_name>
    <description>Pulling/pushing task</description>
    <arm_group_label>Participants</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Voice therapy: loud</intervention_name>
    <description>Assertive task</description>
    <arm_group_label>Participants</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Voice therapy: Semiocclusion</intervention_name>
    <description>Semi-occluded vocal tract</description>
    <arm_group_label>Participants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults in age range who volunteer

          -  Can understand and complete directions presented in English

          -  People with voice disorder associated with advancing age will be included, including
             bowing, incomplete closure, mild edema, erythema, signs of laryngopharyngeal reflux.

        Exclusion Criteria:

          -  Laryngeal differences not related to aging (e.g., vocal fold paralysis,
             moderate-severe edema, lesions, leukoplakia, dysplasia, Parkinson disease)

          -  Known history of stroke, brain injury, or other neurological disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robin A Samlan, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arizona</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robin A Samlan, Ph.D.</last_name>
    <phone>520-621-8618</phone>
    <email>rsamlan@email.arizona.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Natalie Monahan, M.S.</last_name>
    <phone>520-621-4655</phone>
    <email>nmonahan@email.arizona.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie C Zacharias, PhD</last_name>
      <phone>480-301-4932</phone>
      <email>zacharias.stephanie@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>David Lott, MD</last_name>
      <phone>480-342-2983</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85721</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robin A Samlan, PhD</last_name>
      <phone>520-621-8618</phone>
      <email>rsamlan@email.arizona.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>September 17, 2018</study_first_submitted>
  <study_first_submitted_qc>October 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2018</study_first_posted>
  <last_update_submitted>June 9, 2020</last_update_submitted>
  <last_update_submitted_qc>June 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dysphonia</mesh_term>
    <mesh_term>Hoarseness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

